Publications
1. Chuang, E., Barnard, D., Hettich, L., Zhang, X, Avruch, J., and Marshall, M.S. Critical Binding and Regulatory Interactions between Ras and Raf Occur through a Small, Stable N-Terminal Domain of Raf and Specific Ras Effector Residues. Mol. and Cell. Bio. Aug. 1994 p. 5318-5324
2. Barnard, D., Diaz, B., Hettich, L., Chuang, E., Zhang, X., Avruch, J., and Marshall, M. S. Identification of the sites of Interaction Between c-RAF-1 and Ras-GTP. Oncogene Apr. 1995 p.1283-90.
3. Alegre, M.-L., Noel, P.J., Eisfelder, B.J., Chuang, E., Clark, M. R., Reiner, S.L, and C.B. Thompson. Regulation of Surface and Intracellular Expression of CTLA4 on Mouse T Cells. J. Immunology, Dec. 1996 p.4762-4770.
4. Chuang, E., Alegre, M.-L, Duckett, C.S., Noel, P.J., Vander Heiden, M.G., and Thompson, C.B. Interaction of CTLA-4 with the Clathrin-Associated Protein AP50 Results in Ligand-Independent Endocytosis that Limits Cell Surface Expression. J. Immunology, July 1997 p.144-151.
5. Lee, K.-M., Chuang, E., Griffin, M., Khattri, R., Hong, D.K., Zhang, W., Straus, D., Samelson, L.E., Thompson, C.B., and Bluestone, J.A. Molecular Basis of T cell Inactivation by CTLA-4. Science, Dec. 1998 p. 2283-2266.
6. Chuang, E., Lee, K.-M., Robbins, M.C., Duerr, J.M., Alegre, M.-L., Hambor, J.E., Neveu, M.J., Bluestone, J.A., and Thompson, C.B. Regulation of CTLA-4 by Src Kinases. J. Immunology, Feb. 1999 p. 1270-1277.
7. Chuang E., Masteller, E.L., Mullen, A.C., Reiner, S.L., and Thompson, C.B. S. Structural Analysis of CTLA-4 Function in Vivo. J. Immunology, May 2000 p. 5319-5327.
8. Chuang, E., Fisher, T.S., Robbins, M.D., Duerr, J.M., Morgan R.W., VanderHeiden, M.G., Gardner J.P., Hambor J.E., Neveu, M.J., and Thompson, C.B. The CD28 and CTLA-4 Receptors Associate with the Serine/Threonine Phosphatase PP2A. Immunity, September 2000 p. 313-322.
9. Parnes, H.L., Cirrincione, C., Aisner, J., Barry, D.A., Allen, S.L., Abrams, J., Chuang, E, Cooper, M.R., Perry, M.C., Duggan, T.P., Strakowski, T.P., Henderson, I.C., and Norton, L. A Phase III Study of CAF versus CAF plus Leucovorin for Metastatic Breast Cancer: CALGB 9140. Journal of Clinical Oncology, May 2003 p. 1819-24.
10. Yi, L.A., Hajialiasgar, H., and Chuang, E. Tyrosine-mediated inhibitory signals contribute to CTLA-4 function in vivo. International Immunology, April 2004 p. 539-47.
11. Kwang W.H., Sweatt, W.B., Mashayekhi, M., Palucki, D.A., Sattar, H., Chuang, E., and Alegre, M.-L. Transgenic Expression of CTLA-4 Controls Lymphoproliferation in IL-2-Deficient Mice. J. Immunology, Nov. 2004 p. 5415-24.
12. Cheung, K., Tam, W., Chuang, E., Osborne, M. Concurrent invasive ductal carcinoma and chronic lymphocytic leukemia manifesting as a collision tumor in breast. Breast J. 2007 Jul-Aug;13(4):413-7.
13. Naik, R.P., Jin, D., Chuang, E. Gold, E.G., Tousimis, E.A., Moore, A.L., Christos, P.J., deDalmas, T., Donovan, D., Rafii, S. and Vahdat, L.T. Circulating endothelial progenitor cells correlate to stage in patients with invasive breast cancer. Breast Cancer Research and Treatment. 2008 Jan;107(1):133-8.
